N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1
摘要:
We report the synthesis and in vitro activity of a series of novel N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs. These analogs showed potent inhibitory activity against Kv1.3. Several compounds, including compound 8b, showed similar potency to the known Kv1.3 inhibitor PAP-1 when tested under the IonWorks patch clamp assay conditions. (C) 2010 Published by Elsevier Ltd.
作者:David S. Laitar、John W. Kramer、Bryan T. Whiting、Emil B. Lobkovsky、Geoffrey W. Coates
DOI:10.1039/b913698c
日期:——
4-Substituted oxazolines, which are readily synthesized from naturally occurring α-amino acids, are converted efficiently and stereospecifically to β-amidoaldehydes in the presence of synthesis gas and catalytic dicobalt octacarbonyl.
[EN] IMAGING AND RADIOTHERAPY METHODS FOR TUMOUR STEM CELLS<br/>[FR] PROCÉDÉS D'IMAGERIE ET DE RADIOTHÉRAPIE POUR LES CELLULES SOUCHES TUMORALES
申请人:GE HEALTHCARE LTD
公开号:WO2013048811A1
公开(公告)日:2013-04-04
The present invention relates to in vivo imaging and radiotherapeutic methods and agents which target the enzyme aldehyde dehydrogenase (ALDH) and that are suitable for the in vivo imaging of tumours and treatment of cancer.
The present invention relates to in vivo imaging and radiotherapeutic methods and agents which target the enzyme aldehyde dehydrogenase (ALDH) and that are suitable for the in vivo imaging of tumours and treatment of cancer.
[EN] IMAGING AND RADIOTHERAPY METHODS<br/>[FR] PROCÉDÉS D'IMAGERIE ET DE RADIOTHÉRAPIE
申请人:GE HEALTHCARE LTD
公开号:WO2010048144A2
公开(公告)日:2010-04-29
The present invention relates to in vivo imaging and radiotherapeutic methods and agents which target the enzyme aldehyde dehydrogenase (ALDH ) and that are suitable for the in vivo imaging of tumours and treatment of cancer.